Table 2.
Clinical characteristics, treatments, and outcomes.
| Patient no. (age/sex) | Comorbidities | Stroke history | NIHSS at admission | Occlusion site | IV t-PA | Cervical ICA stent size/mm | TIMI post-procedure | TICI post-procedure | NIHSS at discharge | Length of hospital stay/days | Discharge destination | mRs score at 90 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 (64/M) | E | None | 21 | L ICA and L MCA | Yes | Wallstent, EverFlex 7 × 50a | 3 | 3 | 6 | 15 | Home | 1 |
| 2 (66/F) | HTN, S, HC | Several TIAs | 23 | L ICA and L tICA | No | EverFlex 8 × 60 | 3 | 2b | 4 | 35 | Home | 1 |
| 3 (82/F) | HTN, E | None | 14 | L ICA and L M1 | No | Precise 8 × 40 | 3 | 3 | 6 | 5 | Home | 1 |
| 4 (59/M) | S | None | 10 | R ICA and R tICA | No | Precise 8 × 30 | 3 | 3 | 0 | 1 | Home | 1 |
| 5 (50/M) | S | None | 26 | L ICA, L tICA, and LMCA | Yes | Precise, Protege 8 × 40a | 3 | 3 | 2 | 10 | Stroke rehabilitation centre | 1 |
| 6 (63/M) | E | None | 19 | R ICA and R MCA | No | Wallstent 9 × 40 | 3 | 3 | 10 | 35 | Stroke rehabilitation centre | 1 |
| 7 (81/M) | None | 1 | 15 | L ICA, L MCA, L M2, and L A2 | No | Wallstent 9 × 40 | 3 | 3 | 6 | 4 | Stroke rehabilitation centre | 1 |
E: ex-smoker; HC: hypercholesterolaemia; HTN: hypertension; ICA: internal carotid artery; IV: intravenous; L: left; MCA: middle cerebral artery; mRs: modified Rankin scale; NIHSS: National Institutes of Health Stroke Scale; R: right; S: smoker; TIA: transient ischaemic attack; tICA: terminal internal carotid artery; t-PA: tissue plasminogen activator.
a
Indicates 2nd cervical ICA stent deployed after intracranial reperfusion.